As of 2025-11-17, the Relative Valuation of Mirum Pharmaceuticals Inc (MIRM) is (11.60) USD. This relative valuation is based on P/E multiples. With the latest stock price at 71.44 USD, the upside of Mirum Pharmaceuticals Inc based on Relative Valuation is -116.2%.
The range of the Relative Valuation is (8.60) - (15.58) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 4.9x - 13.3x | 9.1x |
| Forward P/E multiples | 7.3x - 14.1x | 10.7x |
| Fair Price | (8.60) - (15.58) | (11.60) |
| Upside | -112.0% - -121.8% | -116.2% |
| Date | P/E |
| 2025-11-14 | -60.98 |
| 2025-11-13 | -59.11 |
| 2025-11-12 | -60.41 |
| 2025-11-11 | -60.88 |
| 2025-11-10 | -59.50 |
| 2025-11-07 | -58.14 |
| 2025-11-06 | -57.80 |
| 2025-11-05 | -59.83 |
| 2025-11-04 | -60.58 |
| 2025-11-03 | -60.47 |
| 2025-10-31 | -62.01 |
| 2025-10-30 | -61.63 |
| 2025-10-29 | -60.14 |
| 2025-10-28 | -60.18 |
| 2025-10-27 | -61.10 |
| 2025-10-24 | -59.77 |
| 2025-10-23 | -59.24 |
| 2025-10-22 | -59.41 |
| 2025-10-21 | -58.88 |
| 2025-10-20 | -62.33 |
| 2025-10-17 | -62.76 |
| 2025-10-16 | -63.52 |
| 2025-10-15 | -65.03 |
| 2025-10-14 | -62.55 |
| 2025-10-13 | -61.60 |
| 2025-10-10 | -62.06 |
| 2025-10-09 | -63.01 |
| 2025-10-08 | -62.18 |
| 2025-10-07 | -62.94 |
| 2025-10-06 | -61.91 |
| 2025-10-03 | -62.27 |
| 2025-10-02 | -61.24 |
| 2025-10-01 | -62.31 |
| 2025-09-30 | -62.57 |
| 2025-09-29 | -62.18 |
| 2025-09-26 | -62.10 |
| 2025-09-25 | -62.80 |
| 2025-09-24 | -63.38 |
| 2025-09-23 | -62.84 |
| 2025-09-22 | -63.10 |
| 2025-09-19 | -63.49 |
| 2025-09-18 | -64.29 |
| 2025-09-17 | -62.43 |
| 2025-09-16 | -62.98 |
| 2025-09-15 | -63.32 |
| 2025-09-12 | -63.43 |
| 2025-09-11 | -64.86 |
| 2025-09-10 | -63.92 |
| 2025-09-09 | -66.31 |
| 2025-09-08 | -66.06 |